{"id":6571,"date":"2021-03-04T08:19:50","date_gmt":"2021-03-04T07:19:50","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/03\/YSOPIA-Bioscience-04-03.pdf"},"modified":"2021-03-04T08:19:50","modified_gmt":"2021-03-04T07:19:50","slug":"ysopia-bioscience-04-03","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/ysopia-bioscience-04-03\/","title":{"rendered":"YSOPIA Bioscience 04 03"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6571","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n